The Possible Preventative Role of Lactate- and Butyrate-Producing Bacteria in Colorectal Carcinogenesis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The gut microbiome has emerged as a key player that mechanistically links various risk factors to colorectal cancer (CRC) etiology. However, the role of the gut microbiome in CRC pathogenesis remains unclear. This study aimed to characterize the gut microbiota in healthy controls (HCs) and patients with colorectal adenoma (AD) and CRC in subgroups based on sex and age. Methods: Study participants who visited the hospital for surveillance of CRC or gastrointestinal symptoms were prospectively enrolled, and the gut microbiome was analyzed based on fecal samples. Results: In terms of HC-AD-CRC sequence, commensal bacteria, including lactate-producing (Streptococcus salivarius) and butyrate-producing (Faecalibacterium prausnitzii, Anaerostipes hadrus, and Eubacterium hallii) bacteria, were more abundant in the HC group than in the AD and CRC groups. In the sex comparison, the female HC group had more lactate-producing bacteria (Bifidobacterium adolescentis, Bifidobacterium catenulatum, and Lactobacillus ruminis) than the male HC group. In age comparison, younger subjects had more butyrate-producing bacteria (Agathobaculum butyriciproducens and Blautia faecis) than the older subjects in the HC group. Interestingly, lactate-producing bacteria (B. catenulatum) were more abundant in females than males among younger HC group subjects. However, these sex- and age-dependent differences were not observed in the AD and CRC groups. Conclusions: The gut microbiome, specifically lactate- and butyrate-producing bacteria, which were found to be abundant in the HC group, may play a role in preventing the progression of CRC. In particular, lactate-producing bacteria, which were found to be less abundant in healthy male controls may contribute to the higher incidence of CRC in males.
Abstract
Background/Aims: The gut microbiome has emerged as a key player that mechanistically links various risk factors to colorectal cancer (CRC) etiology. However, the role of the gut microbiome in CRC pathogenesis remains unclear. This study aimed to characterize the gut microbiota in healthy controls (HCs) and patients with colorectal adenoma (AD) and CRC in subgroups based on sex and age. Methods: Study participants who visited the hospital for surveillance of CRC or gastrointestinal symptoms were prospectively enrolled, and the gut microbiome was analyzed based on fecal samples. Results: In terms of HC-AD-CRC sequence, commensal bacteria, including lactate-producing (Streptococcus salivarius) and butyrate-producing (Faecalibacterium prausnitzii, Anaerostipes hadrus, and Eubacterium hallii) bacteria, were more abundant in the HC group than in the AD and CRC groups. In the sex comparison, the female HC group had more lactate-producing bacteria (Bifidobacterium adolescentis, Bifidobacterium catenulatum, and Lactobacillus ruminis) than the male HC group. In age comparison, younger subjects had more butyrate-producing bacteria (Agathobaculum butyriciproducens and Blautia faecis) than the older subjects in the HC group. Interestingly, lactate-producing bacteria (B. catenulatum) were more abundant in females than males among younger HC group subjects. However, these sex- and age-dependent differences were not observed in the AD and CRC groups. Conclusions: The gut microbiome, specifically lactate- and butyrate-producing bacteria, which were found to be abundant in the HC group, may play a role in preventing the progression of CRC. In particular, lactate-producing bacteria, which were found to be less abundant in healthy male controls may contribute to the higher incidence of CRC in males.
참고문헌 (42)
- Carethers JM, "Genetics and genetic biomarkers in sporadic colorectal cancer", Gastroenterology, 149, pp.1177~1190 (2015)
- Strum WB, "Colorectal adenomas", N Engl J Med, 374, pp.1065~1075 (2016)
- Kim SE, "Sexand gender-specific disparities in colorectal cancer risk", World J Gastroenterol, 21, pp.5167~5175 (2015)
- Gierisch JM, "Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers : a systematic review", Cancer Epidemiol Biomarkers Prev, 22, pp.1931~1943 (2013)
- Chlebowski RT, "Estrogen plus progestin and colorectal cancer in postmenopausal women", N Engl J Med, 350, pp.991~1004 (2004)
- Baker JM, "Estrogengut microbiome axis : physiological and clinical implications", Maturitas, 103, pp.45~53 (2017)
- Cox-York KA, "Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats", Physiol Rep, 3, pp.e12488~ (2015)
- Song CH, "17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice", Sci Rep, 10, pp.12283~ (2020)
- Chen KL, "Estrogen and microbiota crosstalk : should we pay attention?", Trends Endocrinol Metab, 27, pp.752~755 (2016)
- Koliada A, "Sex differences in the phylum-level human gut microbiota composition", BMC Microbiol, 21, pp.131~ (2021)
- Hibberd AA, "Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention", BMJ Open Gastroenterol, 4, pp.e000145~ (2017)
- Hua H, "Intestinal microbiota in colorectal adenoma-carcinoma sequence", Front Med(Lausanne), 9, pp.888340~ (2022)
- Li J, "Comparison of gut microbiota structure and Actinobacteria abundances in healthy young adults and elderly subjects : a pilot study", BMC Microbiol, 21, pp.13~ (2021)
- Sears CL, "Microbes, microbiota, and colon cancer", Cell Host Microbe, 15, pp.317~328 (2014)
- Wu N, "Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model", World J Gastroenterol, 28, pp.1981~1995 (2022)
- So D, "Dietary fiber intervention on gut microbiota composition in healthy adults : a systematic review and meta-analysis", Am J Clin Nutr, 107, pp.965~983 (2018)
- Smith PM, "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis", Science, 341, pp.569~573 (2013)
- Salazar N, "Age-associated changes in gut microbiota and dietary components related with the immune system in adulthood and old age : a crosssectional study", Nutrients, 11, pp.1765~ (2019)
- Bolger AM, "Trimmomatic : a flexible trimmer for Illumina sequence data", Bioinformatics, 30, pp.2114~2120 (2014)
- Masella AP, "PANDAseq : paired-end assembler for illumina sequences", BMC Bioinformatics, 13, pp.31~ (2012)
- Eddy SR, "Accelerated profile HMM searches", PLoS Comput Biol, 7, pp.e1002195~ (2011)
- Lee B, "DUDE-Seq : fast, flexible, and robust denoising for targeted amplicon sequencing", PLoS One, 12, pp.e0181463~ (2017)
- Edgar RC, "Search and clustering orders of magnitude faster than BLAST", Bioinformatics, 26, pp.2460~2461 (2010)
- Edgar RC, "UCHIME improves sensitivity and speed of chimera detection", Bioinformatics, 27, pp.2194~2200 (2011)
- Fu L, "CD-HIT : accelerated for clustering the next-generation sequencing data", Bioinformatics, 28, pp.3150~3152 (2012)
- Segata N, "Metagenomic biomarker discovery and explanation", Genome Biol, 12, pp.R60~ (2011)
- Hidalgo-Cantabrana C, "Bifidobacteria and their healthpromoting effects", Microbiol Spectr, 5, pp.BAD-0010-2016.~ (2017)
- Magne F, "The Firmicutes", Bacteroidetes ratio : a relevant marker of gut dysbiosis in obese patients?, 2020, pp.12, 1474~
- Bervoets L, "Differences in gut microbiota composition between obese and lean children : a cross-sectional study", Gut Pathog, 5, pp.10~ (2013)
- Kim YS, "Sex differences in gut microbiota", World J Mens Health, 38, pp.48~60 (2020)
- Stojanov S, "The influence of probiotics on the Firmicutes", Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease, 2020, pp.8, 1715~
- Jašarević E, "Sex differences in the gut microbiome-brain axis across the lifespan", Philos Trans R Soc Lond B Biol Sci, 371, pp.20150122~ (2016)
- Klein SL, "Sex differences in immune responses", Nat Rev Immunol, 16, pp.626~638 (2016)
- Loh G, "Role of commensal gut bacteria in inflammatory bowel diseases", Gut Microbes, 3, pp.544~555 (2012)
- Wang N, "Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer", Trends Microbiol, 31, pp.159~172 (2023)
- Drewes JL, "High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia", NPJ Biofilms Microbiomes, 3, pp.34~ (2017)
- Islam MR, "The role of gut microbiota and metabolites in obesityassociated chronic gastrointestinal disorders", Nutrients, 14, pp.624~ (2022)
- Wu N, "Dysbiosis signature of fecal microbiota in colorectal cancer patients", Microb Ecol, 66, pp.462~470 (2013)
- Vemuri R, "The microgenderome revealed : sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility", Semin Immunopathol, 41, pp.265~275 (2019)
- Bourriaud C, "Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident", J Appl Microbiol, 99, pp.201~212 (2005)
- Saez-Lara MJ, "The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases : a systematic review of randomized human clinical trials", Biomed Res Int, 2015, pp.505878~ (2015)
- Liu C, "Anti-cancer substances and safety of lactic acid bacteria in clinical treatment", Front Microbiol, 12, pp.722052~ (2021)